Nuclear Imaging

Molecular Imaging

Nuclear Imaging

September 24, 2014 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery IQ PET/CT (positron emission tomography/computed tomography) system.

August 5, 2014 — GE Healthcare announced the first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission tomography/magnetic resonance) is 510(k) pending at the U.S. Food and Drug Administration (FDA)....

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging techni...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone....
A study from Massachusetts General Hospital (MGH) investigators has identified for the first time changes in the metabolic activity of a key brain region in...
Siemens Healthcare has introduced the Symbia Evo Excel SPECT (single-photon emission computed tomography) system—a new version of the company’s Symbia E system...
SPECT imaging, Vancouver, psychiatry, mental health
A new study by clinicians and researchers from Toronto and Vancouver, Canada, found that psychiatric patients who underwent SPECT-...
Siemens Healthcare's Symbia Evo Excel SPECT (single-photon emission computed tomography) system, a new version of the company’s Symbia E
Navidea Biopharmaceuticals' Inc. Lymphoseek (technetium Tc 99m tilmanocept) injection is U.S. Food and Drug Administration (FDA)-...
501(k)-cleared by the U.S. Food and Drug Administration (FDA), GE Healthcare's Discovery IQ PET/CT (positron emission tomography/computed...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the...

Articles

Physicians at Northwestern Memorial Hospital in Chicago were as stunned in 1979 by Godfrey Hounsfield’s exclamation as Hounsfield was at the computed...
Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
Remember the race to map the human genome, when the widest international collaboration in history went up against the efforts of a private corporation, Celera...
August 5, 2014 — GE Healthcare announced the first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission...

Video Center

All major technology advances in the world of radiology and imaging are unveiled or highlighted at...
3 weeks 17 hours ago
Remember the race to map the human genome, when the widest international collaboration in history...
7 weeks 4 days ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
11 weeks 6 days ago
The CME webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" will educate participants in the state of the art clinical and emerging...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
The webinar "Any Image, Anywhere" explains the new ways radiologists and clinicians can boost productivity, optimize scarce resources, and connect their...